Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,286,159
-
Share change
-
+18,302
-
Total reported value
-
$12,357,000
-
Price per share
-
$3.76
-
Number of holders
-
16
-
Value change
-
+$58,225
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) as of Q2 2016
As of 30 Jun 2016 IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,286,159 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., MARATHON ASSET MANAGEMENT LP, INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, Granite Investment Partners, LLC, BARD ASSOCIATES INC, NORTHERN TRUST CORP, BlackRock Fund Advisors, Berson & Corrado Investment Advisors, LLC, and Marathon Capital Management.
This table shows 16 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.